Agios Pharmaceuticals appoints Jay Backstrom to board

Agios Pharmaceuticals (AGIO) appointed Jay Backstrom to its Board of Directors, effective immediately. Backstrom brings decades of leadership experience spanning large pharmaceutical companies, mid-sized biotech firms, and early-stage biopharma organizations, most recently, as President and CEO of Scholar Rock. Previously, he served as EVP of R&D at Acceleron Pharma, acquired by Merck in 2021, and as Chief Medical Officer and Head of Global Regulatory Affairs at Celgene Corporation. Backstrom will serve on Agios’ Science and Technology Committee.